Announced Mon, 13 Apr · 17:52 IST

Compliances Certificate under 74 (5) of SEBI

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+8.4%1-day move

₹2.63

prior close

₹2.54

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+3.9+8.4+18.6+17.5+11.8+11.8+8.4+14.8+21.7+10.3+32.7

Up moveDown movePending

AI summary

Transgene Biotek Ltd has submitted a compliance certificate to BSE under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018. The certificate, issued by Bigshare Services Private Limited (the company's Registrar and Share Transfer Agent) and dated 04th April 2026, covers the period from 01st January 2026 to 31st March 2026. The RTA confirms that no dematerialization requests for equity shares were received during this period through either NSDL or CDSL. This is a routine regulatory filing confirming the status of physical-to-dematerialized share conversion requests. The company (CIN: L85195AP1990PLC011065) is listed on BSE with scrip code 526139.

Likely market impact

This is a routine administrative compliance filing and has no material impact on the company's financials or shareholder value. It simply confirms zero dematerialization activity during the quarter.